Effects of nandrolone on acute morphine responses, tolerance and dependence in mice

European Journal of Pharmacology

Volumn 465, Issue 1-2, 2003, Pages 69-81

  Célérier, Evelyne ^a   Yazdi, Maryam T ^b   Castañé, Anna ^a   Ghozland, Sandy ^a   Nyberg, Fred ^b   Maldonado, Rafael ^a  

^a UNIVERSITAT POMPEU FABRA   (Spain)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

(Mouse); Anabolic androgenic steroid; Dependence; Hypothermia; Morphine tolerance; Nandrolone; Reward

Indexed keywords

ANABOLIC AGENT; ANDROGEN; MORPHINE; NANDROLONE;

ADAPTATION; ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; ATTENUATION; BEHAVIOR; CONTROLLED STUDY; DRUG EFFECT; DRUG EXPOSURE; DRUG MECHANISM; HOT PLATE TEST; HYPOTHERMIA; LOCOMOTION; MALE; MORPHINE ADDICTION; MORPHINE TOLERANCE; MOUSE; NEUROBIOLOGY; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; REWARD; SENSITIZATION; SOMATOSENSORY SYSTEM; WITHDRAWAL REFLEX;

EID: 12244288629     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(03)01462-6     Document Type: Article

References (53)

1. Arvary D., Pope H.G. Jr. Anabolic-androgenic steroids as a gateway to opioid dependence. New Engl. J. Med. 342:2000;1532.
2. Bahrke M.S., Yesalis C.E., Wright J.E. Psychological and behavioural effects of endogenous testosterone and anabolic-androgenic steroids. An update. Sport Med. 22:1996;367-390.
3. Benamar K., Xin L., Geller E.B., Adler M.W. Effect of central and peripheral administration of a nitric oxide synthase inhibitor on morphine hyperthermia in rats. Brain Res. 894:2001;266-273.
4. Bhargava H.N. Diversity of agents that modify opioid tolerance, physical dependence, abstinence syndrome, and self-administrative behavior. Pharmacol. Rev. 46:1994;293-324.
5. Boyer J.S., Morgan M.M., Craft R.M. Microinjection of morphine into the rostral ventromedial medulla produces greater antinociception in male compared to female rats. Brain Res. 796:1998;315-318.
6. Brower K.J., Blow F.C., Young J.P., Hill E.M. Symptoms and correlates of anabolic-androgenic steroid dependence. Br. J. Addict. 86:1991;759-768.
7. Clark A.S., Lindenfeld R.C., Gibbons C.H. Anabolic-androgenic steroids and brain reward. Pharmacol. Biochem. Behav. 53:1996;741-745.
8. Di Chiara G. The role of dopamine in drug abuse viewed from the perspective of its role in motivation. Drug Alcohol Depend. 38:1995;95-137.
9. DuRant R.H., Vaughn R.I., Ashworth C.S., Newman C., Slavens G. Use of multiple drugs among adolescents who use anabolic steroids. N. Eng. J. Med. 32:1993;922-926.
10. Falkenstein E., Tillmann H.-C., Christ M., Feuring M., Wehling M. Multiple actions of steroid hormones - a focus on rapid, non genomic effects. Pharmacol. Rev. 52:2000;513-556.
11. Geller E.B., Hawk C., Keinath S.H., Tallarida R.J., Adler M.W. Subclasses of opioids based on body temperature change in rats: acute subcutaneous administration. J. Pharmacol. Exp. Ther. 225:1983;391-398.
12. Grossman M.L., Bausbaum A.I., Fields H.L. Afferent and efferent connections of the rat tail flick reflex (a model used to analyse pain control mechanisms). J. Comp. Neurol. 206:1982;9-16.
13. Hallberg M., Johansson P., Kindlundh A.M., Nyberg F. Anabolic androgenic steroids affect the content of substance P and substance P (1-7) in the rat brain. Peptides. 21:2000;845-852.
14. Harlan R.E., Brown H.E., Lynch C.S., D'Souza D., Gracia M.M. The effect on opioid peptides in the rat brain after chronic treatment with the anabolic androgenic steroid, nandrolone decanoate. Brain Res. 853:2000;99-104.
15. Janssen P., Neimegeers C., Dony J. The inhibitory effects of fentanyl (R4263) and other morphine like analgesics, on the warm water induced tail reflex in rats. Arzneim.-Forsch. 13:1963;502-507.
16. Johansson P., Ray A., Zhou Q., Huang W., Karlsson K., Nyberg F. Anabolic androgenic steroids increase β-endorphin levels in the ventral tegmental area in the male rat brain. Neurosci. Res. 27:1997;185-189.
17. Johansson P., Hallberg M., Kindlundh A., Nyberg F. The effect on opioid peptides in the rat brain, after chronic treatment with the anabolic androgenic steroid, nandrolone decanoate. Brain Res. Bull. 51:2000;413-418.
18. Johansson P., Lindquist A.-S., Nyberg F., Fahlke C. The anabolic androgenic steroid nandrolone decanoate affects alcohol intake, defensive behaviors and brain opioid peptides in the rat. Pharmacol. Biochem. Behav. 97:2000;1-9.
19. Kamel H.K., Perry H.M., Morley J.E. Hormone replacement therapy and fractures in older adults. J. Am. Geriatr. 49(2):2001;179-187.
20. Kashkin K.B., Kleber H.D. Hooked on hormones? An anabolic steroid addiction hypothesis. JAMA. 262:1989;3166-3170.
21. Kindlundh A., Isacson D.G.L., Berglund L., Nyberg F. Factors associated with adolescent use of doping agents: anabolic-androgenic steroids. Addiction. 94:1999;543-553.
22. Kindlundh A.S., Lindblom J., Bergström L., Wikberg J.E.S., Nyberg F. The anabolic-androgenic steroid nandrolone decanoate affects the density of dopamine receptors in the male rat brain. Eur. J. Neurosci. 13:2001;291-296.
23. Koob G.F. Neural mechanisms of drug reinforcement. Ann. N.Y. Acad. Sci. 654:1992;171-191.
24. Koob G.F., Le Moal M. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology. 24:2001;97-129.
25. Krzanowska E.K., Bodnar R.J. Morphine antinociception elicited from the ventrolateral periaqueductal gray is sensitive to sex and gonadectomy differences in rats. Brain Res. 821:1999;224-230.
26. Kuhn C.M. Anabolic steroids. Recent Prog. Horm. Res. 57:2002;411-434.
27. Le Grevès P., Huang W., Johansson P., Thörnwall M., Zhou Q., Nyberg F. Effects of an anabolic androgenic steroid on the regulation of the NMDA receptor NR1, NR2A and NR2B subunit m RNAs in brain regions of the male rat. Neurosci. Lett. 226:1997;61-64.
28. Lukas S.E. Current perspectives on anabolic-androgenic steroid abuse. Trends Pharmacol. Sci. 14:1993;61-68.
29. Maldonado R., Feger J., Fournie-Zaluski M.C., Roques B.P. Differences in physical dependence induced by selective mu or delta opioid agonists and by endogenous enkephalins protected by peptidase inhibitors. Brain Res. 18:1990;247-254.
30. Maldonado R., Negus S., Koob G.F. Precipitation of morphine withdrawal syndrome in rats by administration of mu-, delta- and kappa-selective opioid antagonists. Neuropharmacology. 31:1992;1231-1241.
31. Maldonado R., Stinus L., Gold L.H., Koob G.F. Role of different brain structures in the expression of the physical morphine withdrawal syndrome. J. Pharmacol. Exp. Ther. 261:1992;669-677.
32. Maldonado R., Saiardi A., Valverde O., Samad T.A., Roques B.P., Borrelli E. Absence of opiate rewarding effects in mice lacking dopamine D2 receptors. Nature. 388:1997;586-589.
33. Marshall E. The drug of champions. Science. 242:1988;183-184.
34. McBride A.J., Williamson K., Petersen T. Three cases of nalbuphine hydrochloride dependence associated with anabolic steroid abuse. Br. J. Sports Med. 30:1996;69-70.
35. Menard C.S., Hebert T.J., Dohanich G.P., Harlan R.E. Androgenic-anabolic steroids modify β-endorphin immuno-reactivity in the rat brain. Brain Res. 669:1995;255-256.
36. Morgan M., Sohn J.-H., Liebeskind J. Stimulation of the periaqueductal gray matter inhibits nociception at the supraspinal as well as spinal level. Brain Res. 502:1989;61-66.
37. Negus S.S., Pope H.G., Kanayama G., Wines J.D., Fischer B.D. Lack of evidence for opioid tolerance or dependence in rhesus monkeys following high-dose anabolic-androgenic steroid administration. Psychoneuroendocrinology. 26:2001;789-796.
38. Nikolarakis K.E., Pfeiffer A., Stalla G.K., Herz A. Facilitation of ACTH secretion by morphine is mediated by activation of CRF releasing neurons and sympathetic neuronal pathways. Brain Res. 498:1989;385-388.
39. Orsini J.C., Barone F.C., Armstrong D.L., Wayner M.J. Direct effects of androgens on lateral hypothalamic neuronal activity in the male rat: I. A microiontophoretic study. Brain Res. Bull. 15:1985;293-297.
40. Pope H.G. Jr., Katz D.L. Psychiatric and medical effects of anabolic-androgenic steroids use. A controlled study of 160 athletes. Arch. Gen. Psychiatry. 51:1994;375-382.
41. Schlussman S.D., Zhou Y., Johansson P., Kiuru A., Ho A., Nyberg F., Kreek M.J. Effects of the androgenic anabolic steroid, nandrolone decanoate, on adrenocorticotropin hormone, corticosterone and proopiomelanocortin, corticotropin releasing factor (CRF) and CRF receptor1 mRNA levels in the hypothalamus, pituitary and amygdala of the rat. Neurosci. Lett. 284:2000;190-194.
42. Simerly R.B., Chang C., Muramatsu M., Swanson L.W. Distribution of androgen and oestrogen receptor mRNA-containing cells in the rat brain: an in situ hybridization study. J. Comp. Neurol. 294:1990;76-95.
43. Steiner H., Gerfen C.R. Role of dynorphin and enkephalin in the regulation of striatal output pathways and behavior. Exp. Brain Res. 123:1998;60-76.
44. Tennant F., Black D.L., Voy R.O. Anabolic steroid dependence with opioid-type features. N. Engl. J. Med. 319:1988;578.
45. Thiblin I., Finn A., Ross S.B., Stenfors C. Increased dopaminergic and 5-hydroxytryptaminergic activities in male rat brain following long term treatment with anabolic androgenic steroids. Br. J. Pharmacol. 126:1999;1301-1306.
46. Ulugol A., Dost T., Dokmeci D., Akpolat M., Karadag C.H., Dokmeci I. Involvement of NMDA receptors and nitric oxide in the thermoregulatory effect of morphine in mice. J. Neural Transm. 107:2000;515-521.
47. Van Ree J.M., Gerrits M.A., Vanderschuren L.J. Opioids, reward and addiction: an encounter of biology psychology, and medicine. Pharmacol. Rev. 51:1999;341-396.
48. Williamson D.J., Young A.H. Psychiatric effects of androgenic and anabolic-androgenic steroid abuse in men: a brief review of the literature. J. Psychopharmacol. 6:1992;20-26.
49. Wilson J.D. Androgen abuse by athletes. Endocr. Rev. 9:1988;181-199.
50. Wilson J.D., Griffin J.E. The use and misuse of androgens. Metabolism. 29:1980;1278-1295.
51. Wines J.D., Gruber A.J., Pope H.G. Jr., Lukas S.E. Nalbuphine hydrochloride dependence in anabolic steroid users. Am. J. Addict. 8:1999;161-164.
52. Xin L., Geller E.B., Adler M.W. Body temperature and analgesic effects of selective mu and kappa opioid receptor agonists microdialysed into rat brain. J. Pharmacol. Exp. Ther. 281:1997;499-507.
53. Yesalis C.E., Bahrke M.S. Anabolic-androgenic steroids, current issues. Sports Med. 19:1995;326-340.